Annovis Bio, Inc.ANVSNYSE
Loading
SG&A Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-20.7%
5Y CAGR+4.5%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-20.7%/yr
vs +96.6%/yr prior
5Y CAGR
+4.5%/yr
Recent deceleration
Acceleration
-117.3pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$4.48M-33.1%
2024$6.70M+7.3%
2023$6.24M-30.6%
2022$9.00M+48.5%
2021$6.06M+68.9%
2020$3.59M+332.4%
2019$829366.00+37.7%
2018$602329.00+47.2%
2017$409063.00-